Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine

ORCID: 0000-0001-8901-7850

Publication year:
All
1 - 10 out of 689Page size: 10
Sort by: Title
  1. Published

     Risk of discontinuation of nevirapine due to toxicities in antiretroviral naive and experienced HIV-infected patients with high and low CD4 counts.

    Mocroft, A., Staszewski, S., Weber, R., Gatell, J., Rockstroh, J., Gasiorowski, J., Panos, G., d'Arminio Monforte, A., Rakhmanova, A., Phillips, A. & Lundgren, Jens, 2007, In: Antiviral Therapy. 12, 3, p. 325-33

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

     EuroSIDA: a prospective observational study of chronic HIV Infection across the European Continent.

    Lundgren, Jens, Kirk, Ole & Mocroft, A., 2009, A Decade of HAART. Oxford University Press, p. 195-212

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research

  3. Published

    [Naturally occurring oseltamivir resistance in influenza A.]

    Madsen, L., Nielsen, A. & Lundgren, Jens, 2010, In: Ugeskrift for læger. 172, 32, p. 2165-2167 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    [Heterosexual transmission of HIV in Denmark in 2001. A real risk or a negligible problem?

    Lundgren, Jens, 2001, In: Ugeskrift for Laeger.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis

    Ostergaard, C., Johansen, J., Benfield, T., price, P. & Lundgren, Jens, 2002, In: Clinical and Vaccine Immunology. 9, 3, p. 598-604

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Why START? Reflections that led to the conduct of this large long-term strategic HIV trial

    Lundgren, Jens, Babiker, A., Gordin, F., Emery, S., Fätkenheuer, G., Molina, J., Wood, R., Neaton, J. D. & INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, I. S. T. O. A. T. (. S. G., Apr 2015, In: HIV Medicine. 16 , Suppl 1, p. 1-9 9 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  7. Published

    Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial

    Molina, J., Grund, B., Gordin, F., Williams, I., Schechter, M., Losso, M., Law, M., Ekong, E., Mwelase, N., Skoutelis, A., Wiselka, M. J., Vandekerckhove, L., Benfield, Thomas, Munroe, D., Lundgren, Jens, Neaton, J. D. & INSIGHT START Study Group, I. S. S. G., 2018, In: The Lancet HIV. 5, 4, p. e172-e180

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?

    Mocroft, A., Laut, K., Reiss, P., Gatell, J., Ormaasen, V., Cavassini, M., Hadziosmanovic, V., Mansinho, K., Pradier, C., Vasylyev, M., Mitsura, V., Vandekerckhove, L., Ostergaard, L., Clarke, A., Degen, O., Mulcahy, F., Castagna, A., Sthoeger, Z., Flamholc, L., Sedláček, D. & 2 others, Mozer-Lisewska, I. & Lundgren, Jens, 2018, In: AIDS (London, England). 32, 2, p. 205-215 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    When to start antiretroviral therapy: the need for an evidence base during early HIV infection

    Lundgren, Jens, Babiker, A. G., Gordin, F. M., Borges, A. H. D. & Neaton, J. D., 2013, In: B M C Medicine. 11, p. 148

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    When to start and stop?

    Lundgren, Jens, 2001, In: HIV Medicine.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...69 Next

ID: 13961